Mark J. Enyedy

Insider Reports History

Entity
Individual
Location
C/O Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego, California
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Enyedy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (Right to Buy) 0 $898 K $4.56 Feb 12, 2024 Direct
BIOMARIN PHARMACEUTICAL INC Director Common Stock 6,900 $532 K $77.05 May 21, 2024 Direct
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. CHIEF EXECUTIVE OFFICER, Director Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
LogicBio Therapeutics, Inc. Director Common Stock 0 $2.01 Nov 16, 2022 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 Nov 16, 2022 Direct

Insider Reports Filed by Mark J. Enyedy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMRN BIOMARIN PHARMACEUTICAL INC May 21, 2024 1 0 4 May 23, 2024 Director
IMGN ImmunoGen, Inc. Feb 12, 2024 8 0 4 Feb 12, 2024 CHIEF EXECUTIVE OFFICER, Director
IMGN ImmunoGen, Inc. Feb 2, 2024 3 -588,733 4 Feb 6, 2024 CHIEF EXECUTIVE OFFICER, Director
IMGN ImmunoGen, Inc. Feb 1, 2024 1 0 4 Feb 5, 2024 CHIEF EXECUTIVE OFFICER, Director
BMRN BIOMARIN PHARMACEUTICAL INC Dec 27, 2023 1 0 4 Dec 28, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC Dec 27, 2023 0 0 3 Dec 28, 2023 Director
IMGN ImmunoGen, Inc. Aug 2, 2023 17 -36,072,132 4 Aug 4, 2023 CHIEF EXECUTIVE OFFICER, Director
IMGN ImmunoGen, Inc. Jun 30, 2023 1 21,226 4 Jul 5, 2023 CHIEF EXECUTIVE OFFICER, Director
IMGN ImmunoGen, Inc. Feb 3, 2023 2 0 4 Feb 7, 2023 CHIEF EXECUTIVE OFFICER, Director
LOGC LogicBio Therapeutics, Inc. Nov 16, 2022 2 0 4 Nov 17, 2022 Director
IMGN ImmunoGen, Inc. Jun 30, 2022 1 12,783 4 Jul 5, 2022 CHIEF EXECUTIVE OFFICER, Director
LOGC LogicBio Therapeutics, Inc. Jun 17, 2022 1 0 4 Jun 21, 2022 Director
IMGN ImmunoGen, Inc. May 20, 2022 2 0 4 Dec 27, 2022 CHIEF EXECUTIVE OFFICER, Director
IMGN ImmunoGen, Inc. Feb 4, 2022 1 5,852,000 4 Feb 8, 2022 Chief Executive Officer, Director
IMGN ImmunoGen, Inc. Jun 30, 2021 1 21,246 4 Jul 2, 2021 Chief Executive Officer, Director
LOGC LogicBio Therapeutics, Inc. Jun 11, 2021 1 0 4 Jun 14, 2021 Director